New Combined Therapy Helps Extend Liv... - Prostate Cancer N...

Prostate Cancer Network

5,288 members3,352 posts

New Combined Therapy Helps Extend Lives of Men With Prostate Cancer

Yearofthecow profile image
3 Replies

"Cedars-Sinai Cancer Study Shows Hormone Therapy, Plus Pelvic Lymph Node Treatment, Improves Survival

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.

The study also shows that patients with prostate cancer who didn’t receive androgen deprivation therapy—and who did not receive pelvic lymph node radiation—had a five-year survival of 70%."

cedars-sinai.org/newsroom/n...

"In men with a detectable prostate-specific antigen (PSA) level after prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of patients being free of progression at 5 years. A three-group randomised trial was designed to determine whether incremental gains in patient outcomes can be achieved by adding either 4–6 months of short-term androgen deprivation therapy (ADT) to PBRT, or both short-term ADT and pelvic lymph node radiotherapy (PLNRT) to PBRT."

..............

"The results of this randomised trial establish the benefit oadding short-term ADT to PBRT to prevent progression in prostate cancer. To our knowledge, these are the first such findings to show that extending salvage radiotherapy to treat the pelvic lymph nodes when combined with short-term ADT results in meaningful reductions in progression after prostatectomy in patients with prostate cancer."

thelancet.com/journals/lanc...

Written by
Yearofthecow profile image
Yearofthecow
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Justfor_ profile image
Justfor_

Quoting from the link:

"...However, late toxicity (>3 months after radiotherapy) did not differ significantly between the groups, apart from more late grade 2 or worse blood or bone marrow events in group 3 versus group 2 (one-sided p=0·0060) attributable to the addition of PLNRT in this group."

No free lunch here.

Yearofthecow profile image
Yearofthecow in reply toJustfor_

No free lunch, but it significantly keeps things contained

julianc profile image
julianc

Thanks for posting this, very useful study as I consider my options for SRT.

Not what you're looking for?

You may also like...

Amar Kishan, MD, on Optimal Sequencing of ADT With RT in Nonmetastatic Prostate Cancer

"For patients with nonmetastatic prostate cancer, the optimal sequencing of short-term...
Yearofthecow profile image

Short-term vs Long-Term ADT for High Risk Men

Here's a review of a recent presentation at ASCO 2023 by Artera.ai regarding the use of Artificial...
janebob99 profile image

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

https://healthunlocked.com/redirect?url=https%3A%2F%2Fwww.auajournals.org%2Fdoi%2F10.1097%2FJU.00000
maley2711 profile image

Long-term adjuvant ADT improves results of brachy boost therapy in unfavorable-risk prostate cancer patients

For most unfavorable risk prostate cancer patients, brachy boost therapy is the preferred option....
Tall_Allen profile image

"Pros and Cons of Various Forms of Radiation Therapy vs Radical Prostatectomy for Men in Their 50s"

I have been diagnosed with intermediate non-favorable risk prostate cancer. Currently, we are...
Seat15c profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.